Hsbc Holdings PLC Invests $18.82 Million in Stericycle, Inc. (NASDAQ:SRCL)

Hsbc Holdings PLC acquired a new stake in Stericycle, Inc. (NASDAQ:SRCL) in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 323,944 shares of the business services provider’s stock, valued at approximately $18,821,000. Hsbc Holdings PLC owned approximately 0.35% of Stericycle as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in SRCL. Clearstead Trust LLC acquired a new stake in Stericycle during the 1st quarter worth approximately $25,000. International Assets Investment Management LLC bought a new stake in Stericycle in the 2nd quarter valued at $45,000. GAMMA Investing LLC boosted its stake in Stericycle by 170.9% in the 1st quarter. GAMMA Investing LLC now owns 818 shares of the business services provider’s stock worth $43,000 after purchasing an additional 516 shares during the period. Principal Securities Inc. bought a new position in Stericycle during the 4th quarter worth about $41,000. Finally, Headlands Technologies LLC bought a new stake in shares of Stericycle in the first quarter valued at about $44,000. Institutional investors and hedge funds own 98.82% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the company. Truist Financial increased their price objective on Stericycle from $50.00 to $62.00 and gave the stock a “hold” rating in a report on Tuesday, June 4th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $62.00 price target (down from $69.00) on shares of Stericycle in a research note on Tuesday, June 4th. StockNews.com began coverage on shares of Stericycle in a research report on Tuesday, September 17th. They issued a “hold” rating on the stock. Finally, Keefe, Bruyette & Woods lifted their price target on shares of Stericycle from $135.00 to $142.00 and gave the company an “outperform” rating in a research note on Tuesday, June 4th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, Stericycle presently has an average rating of “Hold” and a consensus target price of $74.00.

Stericycle Price Performance

NASDAQ:SRCL opened at $61.68 on Monday. The stock has a market capitalization of $5.73 billion, a PE ratio of -280.36, a P/E/G ratio of 3.37 and a beta of 1.11. Stericycle, Inc. has a 1-year low of $37.78 and a 1-year high of $61.77. The firm has a fifty day simple moving average of $59.33 and a 200 day simple moving average of $54.86. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 0.55.

Stericycle (NASDAQ:SRCL) last announced its quarterly earnings data on Thursday, July 25th. The business services provider reported $0.61 EPS for the quarter, beating analysts’ consensus estimates of $0.57 by $0.04. The company had revenue of $661.60 million during the quarter, compared to the consensus estimate of $672.07 million. Stericycle had a net margin of 1.37% and a return on equity of 7.94%. On average, research analysts expect that Stericycle, Inc. will post 2.29 EPS for the current fiscal year.

Stericycle Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.